Pryma, D. A., Chin, B. B., Noto, R. B., Dillon, J. S., Perkins, S., Solnes, L., . . . Jimenez, C. (2019). Efficacy and Safety of High-Specific-Activity (131)I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma. J Nucl Med.
Styl cytowania ChicagoPryma, Daniel A., et al. "Efficacy and Safety of High-Specific-Activity (131)I-MIBG Therapy in Patients With Advanced Pheochromocytoma or Paraganglioma." J Nucl Med 2019.
Styl cytowania MLAPryma, Daniel A., et al. "Efficacy and Safety of High-Specific-Activity (131)I-MIBG Therapy in Patients With Advanced Pheochromocytoma or Paraganglioma." J Nucl Med 2019.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..